Cardiac stem cell therapies may get boost from new FDA

The FDA may not require companies to prove that stem cell therapies are safe and effective prior to approval. Cardiac stem cell therapy could gain FDA approval far earlier than most people expect, despite the fact that these therapies have consistently failed to produce any convincing evidence of safety and efficacy. Under the old FDA ...

Already a member?

Login to keep reading.

© 2021 the limbic